Company
meiragtx.com
MeiraGTx is a clinical-stage genetic medicine company committed to harnessing the full potential of genetic therapies for both rare and prevalent diseases
Also known as MeiraGTx, MeiraGTx Holdings plc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- MeiraGTx Holdings plc
- meiragtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline with four late-stage clinical programs.
Funding snapshot
- Total raised
- $400MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $400M2026-07-07
Funding rounds
- $400 million Strategic Investment
- $400M2026-07-07, Company stated
Loading relationship preview